Toward the next generation of NK cell-based adoptive cancer immunotherapy

OncoImmunology

Volumn 2, Issue 4, 2013, Pages

  Ni, Jing ^a   Miller, Matthias ^a   Stojanovic, Ana ^a   Cerwenka, Adelheid ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Cancer; CD4+ T cells; Immunotherapy; Natural killer cells; Radiation therapy

Indexed keywords

CD11B ANTIGEN; CD27 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 2; LEUKOSIALIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL LECTIN LIKE RECEPTOR;

ADOPTIVE IMMUNOTHERAPY; ADOPTIVE TRANSFER; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CELL EXPANSION; CELLULAR IMMUNITY; CYTOKINE RESPONSE; EFFECTOR CELL; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOPHENOTYPING; IMMUNOSTIMULATION; IN VIVO STUDY; INNATE IMMUNITY; LYMPHOCYTE SUBPOPULATION; MALIGNANT NEOPLASTIC DISEASE; NATURAL KILLER CELL; SOLID TUMOR; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME;

EID: 84886944136     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.23811     Document Type: Article

References (10)

1. Cerwenka A, Lanier LL. Natural killer cells, viruses and cancer. Nat Rev Immunol 2001; 1:41-9; PMID:11905813; http://dx.doi. org/10.1038/35095564
2. Terme M, Ullrich E, Delahaye NF, Chaput N, Zitvogel L. Natural killer cell-directed therapies: moving from unexpected results to successful strategies. Nat Immunol 2008; 9:486-94; PMID:18425105; http:// dx.doi.org/10.1038/ni1580
3. Parkhurst MR, Riley JP, Dudley ME, Rosenberg SA. Adoptive transfer of autologous natural killer cells leads to high levels of circulating natural killer cells but does not mediate tumor regression. Clin Cancer Res 2011; 17:6287-97; PMID:21844012; http://dx.doi. org/10.1158/1078-0432.CCR-11-1347
4. Pegram HJ, Haynes NM, Smyth MJ, Kershaw MH, Darcy PK. Characterizing the anti-tumor function of adoptively transferred NK cells in vivo. Cancer Immunol Immunother 2010; 59:1235-46; PMID:20376439; http://dx.doi.org/10.1007/s00262-010-0848-7
5. Cooper MA, Elliott JM, Keyel PA, Yang L, Carrero JA, Yokoyama WM. Cytokine-induced memorylike natural killer cells. Proc Natl Acad Sci U S A 2009; 106:1915-9; PMID:19181844; http://dx.doi. org/10.1073/pnas.0813192106
6. Ni J, Miller M, Stojanovic A, Garbi N, Cerwenka A. Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors. J Exp Med 2012; 209:2351-65; PMID:23209317; http:// dx.doi.org/10.1084/jem.20120944
7. Lee SH, Fragoso MF, Biron CA. Cutting edge: a novel mechanism bridging innate and adaptive immunity: IL-12 induction of CD25 to form high-affinity IL-2 receptors on NK cells. J Immunol 2012; 189:2712-6; PMID:22888135; http://dx.doi.org/10.4049/jimmunol. 1201528
8. Sun JC, Beilke JN, Lanier LL. Adaptive immune features of natural killer cells. Nature 2009; 457:557-61; PMID:19136945; http://dx.doi.org/10.1038/nature07665
9. O'Leary JG, Goodarzi M, Drayton DL, von Andrian UH. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol 2006; 7:507-16; PMID:16617337; http://dx.doi. org/10.1038/ni1332
10. Romee R, Schneider SE, Leong JW, Chase JM, Keppel CR, Sullivan RP, et al. Cytokine activation induces human memory-like NK cells. Blood 2012; 120:4751-60; PMID:22983442; http://dx.doi.org/10.1182/ blood-2012-04-419283